Zevra Therapeutics Inc. (ZVRA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $9.09
• Market Cap: $502.74M
• P/E Ratio: 19.00
• EPS: $0.47
• 52-Week High: $13.16
• 52-Week Low: $6.19

Market Sentiment

Zevra Therapeutics Inc. currently has a Neutral sentiment score of -0.06.

About Zevra Therapeutics Inc.

Zevra Therapeutics, Inc. is a pioneering biopharmaceutical company headquartered in Celebration, Florida, dedicated to addressing unmet medical needs in rare diseases through its advanced prodrug development platform. The company focuses on developing innovative therapies for serious conditions, leveraging proprietary technology to improve drug efficacy and enhance patient outcomes. With a robust pipeline and a strategic commitment to rare disease therapeutics, Zevra Therapeutics is well-posi...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Zevra Therapeutics Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ZVRA pay dividends?

Zevra Therapeutics Inc. (ZVRA) does not currently pay a regular dividend.

What is ZVRA's P/E ratio?

Zevra Therapeutics Inc. has a price-to-earnings (P/E) ratio of 19.00.

What is ZVRA's market cap?

Zevra Therapeutics Inc. (ZVRA) has a market capitalization of $502.74M with a current stock price of $9.09.